TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 89 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $1,000 | -85.7% | 1,216 | -78.1% | 0.00% | – |
| Q1 2019 | $7,000 | +40.0% | 5,541 | +16.3% | 0.00% | – |
| Q4 2018 | $5,000 | -58.3% | 4,766 | +5.8% | 0.00% | – |
| Q3 2018 | $12,000 | 0.0% | 4,506 | +35.8% | 0.00% | – |
| Q2 2018 | $12,000 | -89.1% | 3,319 | -90.8% | 0.00% | – |
| Q1 2018 | $110,000 | -88.3% | 35,991 | -75.9% | 0.00% | -100.0% |
| Q4 2017 | $939,000 | -12.7% | 149,055 | -5.2% | 0.00% | 0.0% |
| Q3 2017 | $1,075,000 | -27.0% | 157,192 | -23.9% | 0.00% | -25.0% |
| Q2 2017 | $1,473,000 | -3.0% | 206,574 | +25.1% | 0.00% | 0.0% |
| Q1 2017 | $1,518,000 | +188.0% | 165,190 | +26.3% | 0.00% | +100.0% |
| Q4 2016 | $527,000 | +6.2% | 130,809 | +1.0% | 0.00% | +100.0% |
| Q3 2016 | $496,000 | +23.7% | 129,483 | +38.8% | 0.00% | 0.0% |
| Q2 2016 | $401,000 | – | 93,303 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 330,000 | $2,353,000 | 0.98% |
| EcoR1 Capital, LLC | 633,400 | $4,516,000 | 0.80% |
| DLD Asset Management, LP | 570,000 | $4,059,000 | 0.53% |
| Rhenman & Partners Asset Management AB | 300,000 | $2,139,000 | 0.31% |
| Eventide Asset Management | 600,000 | $4,278,000 | 0.27% |
| Tekla Capital Management LLC | 1,004,322 | $7,161,000 | 0.26% |
| Rock Springs Capital Management LP | 698,000 | $4,977,000 | 0.25% |
| DLD Asset Management, LP | 230,000 | $1,640,000 | 0.21% |
| Worth Venture Partners, LLC | 29,325 | $209,000 | 0.18% |
| Crestline Management, LP | 161,403 | $1,151,000 | 0.15% |